Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.

NCT04915768 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: CH505 TF chTrimer
BIOLOGICAL: 3M-05-AF
BIOLOGICAL: Aluminum hydroxide suspension
BIOLOGICAL: 3M-05-AF
BIOLOGICAL: CH505 TF chTrimer

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)